Arega Pharma: what changed
What changed
Arega Pharma
NACE 46.460, Wholesale of pharmaceutical and medical goods
filed annual accounts (NBB)
Net result for the year
€6.4m
2024 · €4.0m+€2.3m
Equity
€9.8m
2024 · €11.2m-€1.4m
Cash
€5,588
2024 · -+€5,588
Balance sheet total
€54.2m
2024 · €43.0m+€11.1m
Largest movements
Assets
- Receivables within one year +€9.9m
up €9.9m (+44.7%), from €22.1m to €31.9m
of which Other amounts receivable: +€6.9m
- Stocks and contracts +€2.5m
up €2.5m (+12.9%), from €19.1m to €21.5m
- Financial fixed assets -€1.4m
down €1.4m (-99.1%), from €1.4m to €12,540
of which Affiliated companies: -€1.4m
Equity and liabilities
- Trade debts +€8.9m
up €8.9m (+39.1%), from €22.7m to €31.6m
- Other debts +€5.0m
new in 2025: €5.0m
- Tax, wage and social debts -€1.7m
down €1.7m (-20.4%), from €8.6m to €6.8m
of which Taxes: -€1.4m
- Profit (loss) carried forward -€1.4m
down €1.4m (-12.6%), from €11.0m to €9.6m
Income statement
- Goods and materials +€7.7m
up €7.7m (+29.0%), from €26.6m to €34.3m
of which Purchases: +€10.0m
- Turnover +€7.5m
up €7.5m (+13.5%), from €55.8m to €63.4m
- Services and other goods +€1.5m
up €1.5m (+12.4%), from €12.3m to €13.8m
- Write-downs +€1.3m
up €1.3m, from -€611,657 to €654,230
- Other operating charges -€1.2m
down €1.2m (-23.1%), from €5.1m to €3.9m
Change in the result, 2024 to 2025
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Result 2024
€4.0m
Turnover
+€7.5m
Other operating income
-€152,856
Goods and materials
-€7.7m
Services and other goods
-€1.5m
Staff costs
+€268,824
Depreciation
-€37,649
Write-downs
-€1.3m
Provisions
-€344,000
Other operating charges
+€1.2m
Other operating items
+€4.3m
Financial income
+€1,619
Financial charges
-€8,486
Taxes
+€52,302
Result 2025
€6.4m
raises the resultlowers the resultnot broken down further in the accounts
Derived cash bridge
The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.
From operations
+€6.6m
Investment
+€1.1m
Financing
-€7.7m
Cash 2024
€0
From operations (derived)
+€6.6m
Net result for the year
+€6.4m
Depreciation
+€159,914
Stocks and contracts
-€2.5m
Receivables within one year
-€9.9m
Deferred charges and accrued income
-€21,963
Provisions
+€244,000
Trade debts
+€8.9m
Tax, wage and social debts
-€1.7m
Other debts
+€5.0m
Accrued charges and deferred income
+€88,522
Investment (derived)
+€1.1m
Investment in fixed assets (net)
+€1.1m
Financing
-€7.7m
Contributions, distributions and other
-€7.7m
Cash 2025
€5,588
brings cash intakes cash out
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €43,048,660 | €54,163,278 | +€11.1m | +25.8% |
| Fixed assets | 21/28 | €1,851,682 | €621,969 | -€1.2m | -66.4% |
| Intangible fixed assets | 21 | €132,130 | €89,664 | -€42,466 | -32.1% |
| Tangible fixed assets | 22/27 | €327,750 | €519,765 | +€192,015 | +58.6% |
| Plant, machinery and equipment | 23 | - | €3,283 | +€3,283 | |
| Furniture and vehicles | 24 | €165,642 | €355,376 | +€189,734 | +115% |
| Other tangible fixed assets | 26 | - | €161,106 | +€161,106 | |
| Assets under construction and advance payments | 27 | €162,108 | €0 | -€162,108 | -100% |
| Financial fixed assets | 28 | €1,391,802 | €12,540 | -€1.4m | -99.1% |
| Affiliated companies | 280/1 | €1,377,379 | €12,540 | -€1.4m | -99.1% |
| Amounts receivable | 281 | €1,377,379 | €12,540 | -€1.4m | -99.1% |
| Other financial fixed assets | 284/8 | €14,423 | €0 | -€14,423 | -100% |
| Amounts receivable and cash guarantees | 285/8 | €14,423 | €0 | -€14,423 | -100% |
| Current assets | 29/58 | €41,196,978 | €53,541,309 | +€12.3m | +30.0% |
| Stocks and contracts in progress | 3 | €19,066,769 | €21,528,353 | +€2.5m | +12.9% |
| Stocks | 30/36 | €19,066,769 | €21,528,353 | +€2.5m | +12.9% |
| Goods purchased for resale | 34 | €19,066,769 | €21,528,353 | +€2.5m | +12.9% |
| Amounts receivable within one year | 40/41 | €22,061,956 | €31,917,151 | +€9.9m | +44.7% |
| Trade receivables | 40 | €8,799,514 | €11,709,859 | +€2.9m | +33.1% |
| Other amounts receivable | 41 | €13,262,442 | €20,207,292 | +€6.9m | +52.4% |
| Cash at bank and in hand | 54/58 | - | €5,588 | +€5,588 | |
| Deferred charges and accrued income | 490/1 | €68,253 | €90,216 | +€21,963 | +32.2% |
| Total equity and liabilities | 10/49 | €43,048,660 | €54,163,278 | +€11.1m | +25.8% |
| Equity | 10/15 | €11,164,710 | €9,801,971 | -€1.4m | -12.2% |
| Contributions | 10/11 | €200,000 | €220,000 | +€20,000 | +10.0% |
| Capital | 10 | - | €220,000 | +€220,000 | |
| Issued capital | 100 | - | €220,000 | +€220,000 | |
| Contributions outside capital | 11 | - | €0 | = | |
| Other | 1109/19 | - | €0 | = | |
| Profit (loss) carried forward | 14 | €10,964,710 | €9,581,971 | -€1.4m | -12.6% |
| Provisions and deferred taxes | 16 | €596,971 | €840,971 | +€244,000 | +40.9% |
| Provisions for liabilities and charges | 160/5 | €596,971 | €840,971 | +€244,000 | +40.9% |
| Environmental obligations | 163 | - | €840,971 | +€840,971 | |
| Other liabilities and charges | 164/5 | €596,971 | - | -€596,971 | |
| Amounts payable | 17/49 | €31,286,979 | €43,520,336 | +€12.2m | +39.1% |
| Amounts payable within one year | 42/48 | €31,283,756 | €43,428,590 | +€12.1m | +38.8% |
| Trade debts | 44 | €22,728,223 | €31,618,368 | +€8.9m | +39.1% |
| Suppliers | 440/4 | €22,728,223 | €31,618,368 | +€8.9m | +39.1% |
| Taxes, remuneration and social security | 45 | €8,555,533 | €6,810,222 | -€1.7m | -20.4% |
| Taxes | 450/3 | €6,858,761 | €5,457,512 | -€1.4m | -20.4% |
| Remuneration and social security | 454/9 | €1,696,772 | €1,352,710 | -€344,062 | -20.3% |
| Other amounts payable | 47/48 | - | €5,000,000 | +€5.0m | |
| Accrued charges and deferred income | 492/3 | €3,223 | €91,745 | +€88,522 | +2,747% |
| Operating income | 70/76A | €56,286,898 | €67,990,287 | +€11.7m | +20.8% |
| Turnover | 70 | €55,848,755 | €63,376,460 | +€7.5m | +13.5% |
| Other operating income | 74 | €438,143 | €285,287 | -€152,856 | -34.9% |
| Non-recurring operating income | 76A | - | €4,328,540 | +€4.3m | |
| Operating charges | 60/66A | €50,604,505 | €60,032,766 | +€9.4m | +18.6% |
| Goods for resale, raw materials and consumables | 60 | €26,553,035 | €34,264,831 | +€7.7m | +29.0% |
| Purchases | 600/8 | €25,860,483 | €35,827,277 | +€10.0m | +38.5% |
| Change in stocks: decrease (increase) | 609 | €692,552 | -€1,562,446 | -€2.3m | |
| Services and other goods | 61 | €12,277,356 | €13,796,906 | +€1.5m | +12.4% |
| Remuneration, social security and pensions | 62 | €7,247,115 | €6,978,291 | -€268,824 | -3.7% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €122,265 | €159,914 | +€37,649 | +30.8% |
| Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) | 631/4 | -€611,657 | €654,230 | +€1.3m | |
| Provisions for liabilities and charges: additions (uses and reversals) | 635/8 | -€100,000 | €244,000 | +€344,000 | |
| Other operating charges | 640/8 | €5,116,391 | €3,934,593 | -€1.2m | -23.1% |
| Operating profit (loss) | 9901 | €5,682,393 | €7,957,521 | +€2.3m | +40.0% |
| Financial income | 75/76B | €2 | €1,621 | +€1,619 | +80,967% |
| Recurring financial income | 75 | €2 | €1,621 | +€1,619 | +80,967% |
| Other financial income | 752/9 | €2 | €1,621 | +€1,619 | +80,967% |
| Financial charges | 65/66B | €113,446 | €121,932 | +€8,486 | +7.5% |
| Recurring financial charges | 65 | €113,446 | €121,932 | +€8,486 | +7.5% |
| Debt charges | 650 | €102,047 | €120,362 | +€18,315 | +17.9% |
| Other financial charges | 652/9 | €11,399 | €1,570 | -€9,829 | -86.2% |
| Profit (loss) for the period before taxes | 9903 | €5,568,949 | €7,837,210 | +€2.3m | +40.7% |
| Income taxes | 67/77 | €1,539,322 | €1,487,020 | -€52,302 | -3.4% |
| Taxes | 670/3 | €1,539,322 | €1,487,020 | -€52,302 | -3.4% |
| Profit (loss) for the period | 9904 | €4,029,627 | €6,350,191 | +€2.3m | +57.6% |
| Profit (loss) for the period to be appropriated | 9905 | €4,029,627 | €6,350,191 | +€2.3m | +57.6% |
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Compare this company with its sector.Sector benchmark
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 3 November 2026 via checked.be.